|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.750 JOD | +4.79% |
|
+4.79% | +9.38% |
| 04-27 | Philadelphia Pharmaceuticals Q1 profit 255,632 dinars | RE |
| 04-26 | Philadelphia Pharmaceuticals Company Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.79% | +4.79% | +4.17% | +16.67% | +9.38% | +16.67% | +29.63% | +25.00% | -41.67% | 18.51M | |
| -0.73% | +0.87% | +6.29% | +16.10% | +11.73% | +14.92% | +78.11% | +187.40% | +145.37% | 48.69B | |
| -2.01% | -3.01% | +7.45% | +2.91% | +23.52% | +63.83% | +113.44% | +149.66% | +123.81% | 36.38B | |
| -0.88% | -2.16% | +2.68% | +16.04% | -5.60% | -3.93% | +39.57% | +48.64% | +176.65% | 12.19B | |
| -1.69% | -0.82% | +2.41% | +23.59% | +23.73% | +15.49% | +90.65% | +75.37% | +204.32% | 12.04B | |
| +1.53% | +1.92% | +1.92% | +10.65% | +30.54% | +33.50% | +125.53% | +148.83% | +371.95% | 9.04B | |
| -1.57% | -2.38% | -0.25% | -7.03% | +20.63% | +16.67% | +36.31% | +45.03% | +101.15% | 7.09B | |
| -1.13% | -0.76% | +8.50% | -4.34% | +10.49% | +48.87% | -5.59% | -4.91% | -40.32% | 7.06B | |
| +0.81% | +4.08% | +5.87% | +6.38% | +13.07% | +5.51% | +240.10% | +250.70% | +174.50% | 6.75B | |
| -5.52% | -12.48% | +12.08% | -44.25% | -29.20% | -22.06% | +9.45% | +16.74% | +24.62% | 6.1B | |
| +2.17% | +2.86% | +9.27% | +21.93% | +23.57% | +30.26% | +140.30% | +137.86% | +219.22% | 4.38B | |
| +2.70% | -4.24% | +3.11% | +10.94% | +29.33% | +29.88% | -16.78% | -12.55% | -60.77% | 4.11B | |
| +3.06% | +8.63% | +23.37% | -9.32% | +4.09% | +19.35% | +65.69% | +3.15% | - | 3.96B | |
| -7.36% | -13.60% | -29.29% | -63.39% | -20.47% | +15.13% | +248.21% | +248.21% | +1,652.61% | 3.11B | |
| +2.42% | -4.33% | -4.31% | +38.00% | +28.23% | +5.54% | +659.11% | +241.21% | +93.12% | 3.08B | |
| +0.66% | +5.52% | +3.96% | -1.35% | +7.21% | +38.70% | +83.52% | +26.11% | +88.88% | 2.86B | |
| -0.31% | -1.22% | -0.69% | -9.69% | -8.54% | -18.18% | +37.87% | +179.91% | +660.12% | 2.77B | |
| -0.81% | -1.28% | -7.16% | -3.30% | +3.02% | -13.05% | +26.60% | - | - | 2.76B | |
| +1.67% | -0.79% | +8.83% | -14.28% | -17.32% | -34.01% | +48.33% | +25.32% | +21.64% | 2.72B | |
| -0.98% | -4.67% | +12.23% | +9.27% | +17.32% | -22.50% | +41.68% | +94.21% | - | 2.63B | |
| Average | -0.16% | -0.70% | +3.52% | +0.78% | +8.74% | +12.03% | +104.59% | +99.26% | +230.31% | 8.89B | |
| Weighted average by Cap. | -0.87% | -0.14% | +5.15% | +6.35% | +13.04% | +23.20% | +94.54% | +128.37% | +175.75% |
- Stock Market
- Stocks
- PHIL Stock
- Sector Philadelphia Pharmaceuticals Company
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
